Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Simvastatin Multiple Sclerosis”

11 trials

Showing 11 of 11 results

Large-scale testing (Phase 3)Study completedNCT00668343
What this trial is testing

Simvastatin in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Using Avonex Compared to Placebo

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Tehran University of Medical Sciences 80
Post-approval studies (Phase 4)Study completedNCT00146068
What this trial is testing

EARLY IFNB-1a and Simvastatin Combination Therapy in Clinically Isolated Syndrome Suggestive of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University of North Carolina 30
Early research (Phase 1)UnknownNCT04178980
What this trial is testing

Role of Simvastatin in Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Simvastatin Multiple Sclerosis
Assiut University 60
Large-scale testing (Phase 3)WithdrawnNCT00429442
What this trial is testing

Simvastatin as an add-on Treatment to Copaxone for the Treatment of Relapsing Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Anna Tsakiri
Testing effectiveness (Phase 2)Study completedNCT02061397
What this trial is testing

Safety of Simvastatin in LAM and TSC

Who this might be right for
LymphangioleiomyomatosisTuberous Sclerosis Complex
University of Pennsylvania 10
Large-scale testing (Phase 3)Study completedNCT03387670
What this trial is testing

Multiple Sclerosis-Simvastatin Trial 2

Who this might be right for
Secondary Progressive Multiple Sclerosis (SPMS)
University College, London 964
Large-scale testing (Phase 3)UnknownNCT00242268
What this trial is testing

A Safety Study of Combination Treatment With Avonex and Zocor in Relapsing Remitting Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Alabama Neurology Associates, PC 30
Testing effectiveness (Phase 2)Study completedNCT00647348
What this trial is testing

Investigation of Simvastatin in Secondary Progressive Multiple Sclerosis

Who this might be right for
Secondary Progressive Multiple Sclerosis
Imperial College London 140
Large-scale testing (Phase 3)UnknownNCT00261326
What this trial is testing

Simvastatin Treatment of Patients With Acute Optic Neuritis

Who this might be right for
Optic NeuritisMultiple Sclerosis
Glostrup University Hospital, Copenhagen 64
Testing effectiveness (Phase 2)Study completedNCT03896217
What this trial is testing

Simvastatin in Secondary Progressive Multiple Sclerosis

Who this might be right for
Secondary Progressive Multiple Sclerosis
University College, London 40
Post-approval studies (Phase 4)Study completedNCT00492765
What this trial is testing

Simvastatin as an Add-on Treatment to Interferon-beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Biogen 380

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation